These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2481312)

  • 1. Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.
    Price M; Lee SC; Deutsch C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10171-5. PubMed ID: 2481312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of human T lymphocyte activation by channel antagonists.
    Bono MR; Simon V; Rosemblatt MS
    Cell Biochem Funct; 1989 Jul; 7(3):219-26. PubMed ID: 2477169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of phospholipid metabolism by K+ channel blockers and inhibitors of choline transport in the Jurkat T cell line. Relationships with cell proliferation and interleukin-2 production.
    Aussel C; Cattan N; Pelassy C; Rossi B
    J Lipid Mediat; 1993 Jun; 7(2):99-113. PubMed ID: 8400120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-mediated agonists activate an inwardly rectified K+ channel in colonic secretory cells.
    Devor DC; Frizzell RA
    Am J Physiol; 1993 Nov; 265(5 Pt 1):C1271-80. PubMed ID: 7694492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.
    Leonard RJ; Garcia ML; Slaughter RS; Reuben JP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10094-8. PubMed ID: 1279670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes.
    Freedman BD; Price MA; Deutsch CJ
    J Immunol; 1992 Dec; 149(12):3784-94. PubMed ID: 1281185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous mixed-lymphocyte reaction in man. XVII. In vitro effect of ion channel-blocking agents on the autologous mixed-lymphocyte response.
    Gupta S
    Cell Immunol; 1987 Feb; 104(2):290-5. PubMed ID: 2434246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific distinctions in potassium channel blocker control of T-lymphocyte activation.
    Dos Reis GA; Nóbrega AF; Persechini PM
    Int J Immunopharmacol; 1988; 10(3):217-26. PubMed ID: 2846451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation.
    Gelfand EW; Or R
    J Immunol; 1991 Nov; 147(10):3452-8. PubMed ID: 1719077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.
    Lin CS; Boltz RC; Blake JT; Nguyen M; Talento A; Fischer PA; Springer MS; Sigal NH; Slaughter RS; Garcia ML
    J Exp Med; 1993 Mar; 177(3):637-45. PubMed ID: 7679705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes.
    Sands SB; Lewis RS; Cahalan MD
    J Gen Physiol; 1989 Jun; 93(6):1061-74. PubMed ID: 2475579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cultured human neuroblastoma cells in rapid discovery of the voltage-gated potassium-channel blockers.
    Toral J; Hu W; Yi L; Barrett JE; Sokol PT; Ziai MR
    J Pharm Pharmacol; 1994 Sep; 46(9):731-4. PubMed ID: 7530770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated potassium channels are required for human T lymphocyte activation.
    Chandy KG; DeCoursey TE; Cahalan MD; McLaughlin C; Gupta S
    J Exp Med; 1984 Aug; 160(2):369-85. PubMed ID: 6088661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of renal tubule epithelial cells by simian virus-40 is associated with emergence of Ca(2+)-insensitive K+ channels and altered mitogenic sensitivity to K+ channel blockers.
    Teulon J; Ronco PM; Geniteau-Legendre M; Baudouin B; Estrade S; Cassingena R; Vandewalle A
    J Cell Physiol; 1992 Apr; 151(1):113-25. PubMed ID: 1373146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-induced changes in Ca2+ permeability are not mediated by voltage-gated K+ channels.
    Gelfand EW; Cheung RK; Grinstein S
    J Biol Chem; 1986 Sep; 261(25):11520-3. PubMed ID: 2427511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of voltage-gated K+ channel pharmacology.
    Pongs O
    Trends Pharmacol Sci; 1992 Sep; 13(9):359-65. PubMed ID: 1382336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking agents of Ca2+-activated K+ channels in cultured medullary thick ascending limb cells.
    Guggino SE; Guggino WB; Green N; Sacktor B
    Am J Physiol; 1987 Feb; 252(2 Pt 1):C128-37. PubMed ID: 2435161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel.
    Candia S; Garcia ML; Latorre R
    Biophys J; 1992 Aug; 63(2):583-90. PubMed ID: 1384740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic basis of the action potential of guinea pig gallbladder smooth muscle cells.
    Zhang L; Bonev AD; Nelson MT; Mawe GM
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1552-61. PubMed ID: 7506489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of interleukin-2 production and phosphatidylserine synthesis in Jurkat T lymphocytes by K+ channel antagonists.
    Aussel C; Pelassy C; Mary D; Choquet D; Rossi B
    Immunopharmacology; 1990; 20(2):97-103. PubMed ID: 2266004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.